234 related articles for article (PubMed ID: 32667139)
1. Molecular and behavioural abnormalities in the FUS-tg mice mimic frontotemporal lobar degeneration: Effects of old and new anti-inflammatory therapies.
de Munter J; Babaevskaya D; Wolters EC; Pavlov D; Lysikova E; V Kalueff A; Gorlova A; Oplatchikova M; Pomytkin IA; Proshin A; Umriukhin A; Lesch KP; Strekalova T
J Cell Mol Med; 2020 Sep; 24(17):10251-10257. PubMed ID: 32667139
[TBL] [Abstract][Full Text] [Related]
2. Neuro-Cells therapy improves motor outcomes and suppresses inflammation during experimental syndrome of amyotrophic lateral sclerosis in mice.
de Munter JPJM; Shafarevich I; Liundup A; Pavlov D; Wolters EC; Gorlova A; Veniaminova E; Umriukhin A; Kalueff A; Svistunov A; Kramer BW; Lesch KP; Strekalova T
CNS Neurosci Ther; 2020 May; 26(5):504-517. PubMed ID: 31867846
[TBL] [Abstract][Full Text] [Related]
3. Transportin 1 colocalization with Fused in Sarcoma (FUS) inclusions is not characteristic for amyotrophic lateral sclerosis-FUS confirming disrupted nuclear import of mutant FUS and distinguishing it from frontotemporal lobar degeneration with FUS inclusions.
Troakes C; Hortobágyi T; Vance C; Al-Sarraj S; Rogelj B; Shaw CE
Neuropathol Appl Neurobiol; 2013 Aug; 39(5):553-61. PubMed ID: 22934812
[TBL] [Abstract][Full Text] [Related]
4. Monomethylated and unmethylated FUS exhibit increased binding to Transportin and distinguish FTLD-FUS from ALS-FUS.
Suárez-Calvet M; Neumann M; Arzberger T; Abou-Ajram C; Funk E; Hartmann H; Edbauer D; Kremmer E; Göbl C; Resch M; Bourgeois B; Madl T; Reber S; Jutzi D; Ruepp MD; Mackenzie IR; Ansorge O; Dormann D; Haass C
Acta Neuropathol; 2016 Apr; 131(4):587-604. PubMed ID: 26895297
[TBL] [Abstract][Full Text] [Related]
5. Aberrant interaction between FUS and SFPQ in neurons in a wide range of FTLD spectrum diseases.
Ishigaki S; Riku Y; Fujioka Y; Endo K; Iwade N; Kawai K; Ishibashi M; Yokoi S; Katsuno M; Watanabe H; Mori K; Akagi A; Yokota O; Terada S; Kawakami I; Suzuki N; Warita H; Aoki M; Yoshida M; Sobue G
Brain; 2020 Aug; 143(8):2398-2405. PubMed ID: 32770214
[TBL] [Abstract][Full Text] [Related]
6. Transportin 1 accumulates specifically with FET proteins but no other transportin cargos in FTLD-FUS and is absent in FUS inclusions in ALS with FUS mutations.
Neumann M; Valori CF; Ansorge O; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ishihara K; Ang LC; Bilbao JM; Mackenzie IR
Acta Neuropathol; 2012 Nov; 124(5):705-16. PubMed ID: 22842875
[TBL] [Abstract][Full Text] [Related]
7. Frontotemporal lobar degeneration and amyotrophic lateral sclerosis: molecular similarities and differences.
Neumann M
Rev Neurol (Paris); 2013 Oct; 169(10):793-8. PubMed ID: 24011641
[TBL] [Abstract][Full Text] [Related]
8. FUS-regulated region- and cell-type-specific transcriptome is associated with cell selectivity in ALS/FTLD.
Fujioka Y; Ishigaki S; Masuda A; Iguchi Y; Udagawa T; Watanabe H; Katsuno M; Ohno K; Sobue G
Sci Rep; 2013; 3():2388. PubMed ID: 23925123
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide triggers exacerbated microglial activation, excessive cytokine release and behavioural disturbances in mice with truncated Fused-in-Sarcoma Protein (FUS).
Trofimov A; Pavlov D; Goswami A; Gorlova A; Chaprov K; Umriukhin A; Kalueff A; Deykin A; Lesch KP; Anthony DC; Strekalova T
Brain Behav Immun Health; 2023 Nov; 33():100686. PubMed ID: 37767237
[TBL] [Abstract][Full Text] [Related]
10. FUS regulates AMPA receptor function and FTLD/ALS-associated behaviour via GluA1 mRNA stabilization.
Udagawa T; Fujioka Y; Tanaka M; Honda D; Yokoi S; Riku Y; Ibi D; Nagai T; Yamada K; Watanabe H; Katsuno M; Inada T; Ohno K; Sokabe M; Okado H; Ishigaki S; Sobue G
Nat Commun; 2015 May; 6():7098. PubMed ID: 25968143
[TBL] [Abstract][Full Text] [Related]
11. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?
Baloh RH
Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957
[TBL] [Abstract][Full Text] [Related]
12. FUS is phosphorylated by DNA-PK and accumulates in the cytoplasm after DNA damage.
Deng Q; Holler CJ; Taylor G; Hudson KF; Watkins W; Gearing M; Ito D; Murray ME; Dickson DW; Seyfried NT; Kukar T
J Neurosci; 2014 Jun; 34(23):7802-13. PubMed ID: 24899704
[TBL] [Abstract][Full Text] [Related]
13. In FUS[1-359]-tg mice O,S-dibenzoyl thiamine reduces muscle atrophy, decreases glycogen synthase kinase 3 beta, and normalizes the metabolome.
Probert F; Gorlova A; Deikin A; Bettendorff L; Veniaminova E; Nedorubov A; Chaprov KD; Ivanova TA; Anthony DC; Strekalova T
Biomed Pharmacother; 2022 Dec; 156():113986. PubMed ID: 36411653
[TBL] [Abstract][Full Text] [Related]
14. Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43).
Bentmann E; Neumann M; Tahirovic S; Rodde R; Dormann D; Haass C
J Biol Chem; 2012 Jun; 287(27):23079-94. PubMed ID: 22563080
[TBL] [Abstract][Full Text] [Related]
15. Fused in sarcoma (FUS): an oncogene goes awry in neurodegeneration.
Dormann D; Haass C
Mol Cell Neurosci; 2013 Sep; 56():475-86. PubMed ID: 23557964
[TBL] [Abstract][Full Text] [Related]
16. Genetic contribution of FUS to frontotemporal lobar degeneration.
Van Langenhove T; van der Zee J; Sleegers K; Engelborghs S; Vandenberghe R; Gijselinck I; Van den Broeck M; Mattheijssens M; Peeters K; De Deyn PP; Cruts M; Van Broeckhoven C
Neurology; 2010 Feb; 74(5):366-71. PubMed ID: 20124201
[TBL] [Abstract][Full Text] [Related]
17. Behavioural impairments in mice of a novel FUS transgenic line recapitulate features of frontotemporal lobar degeneration.
Lysikova EA; Kukharsky MS; Chaprov KD; Vasilieva NA; Roman AY; Ovchinnikov RK; Deykin AV; Ninkina N; Buchman VL
Genes Brain Behav; 2019 Nov; 18(8):e12607. PubMed ID: 31437340
[TBL] [Abstract][Full Text] [Related]
18. Amyotrophic lateral sclerosis and non-tau frontotemporal lobar degeneration.
Hortobágyi T; Cairns NJ
Handb Clin Neurol; 2017; 145():369-381. PubMed ID: 28987183
[TBL] [Abstract][Full Text] [Related]
19. RNA Binding Proteins and the Pathogenesis of Frontotemporal Lobar Degeneration.
Hofmann JW; Seeley WW; Huang EJ
Annu Rev Pathol; 2019 Jan; 14():469-495. PubMed ID: 30355151
[TBL] [Abstract][Full Text] [Related]
20. FUS transgenic rats develop the phenotypes of amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
Huang C; Zhou H; Tong J; Chen H; Liu YJ; Wang D; Wei X; Xia XG
PLoS Genet; 2011 Mar; 7(3):e1002011. PubMed ID: 21408206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
